PCI Biotech: Utøvelse av opsjoner

July 01, 2013 02:00 ET | Source: PCI Biotech Holding ASA PCI Biotech Holding ASA

Primærinnsider i PCI Biotech Holding ASA Bernt-Olav Røttingsnes (CFO) har 28. juni 2013 utøvet 60.000 opsjoner tildelt 22. juni 2009. Utøvelseskurs for opsjonene er 6,47 kroner. Etter opsjonsutøvelsen har Bernt-Olav Røttingsnes 60.000 aksjer i PCI Biotech Holding ASA.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Recommended Reading

October 23, 2025 04:35 ET | Source: PCI Biotech Holding ASA

PCI Biotech update

Oslo (Norway), 23 October 2025 – PCI Biotech (OSE: PCIB) today provides an update on the ongoing evaluation of its operations. Reference is made to the company’s announcements dated 18th August 2025...
Read More
September 25, 2025 09:36 ET | Source: PCI Biotech Holding ASA

PCI Biotech update on future operations

Oslo (Norway), 25 September 2025 – PCI Biotech (OSE:PCIB) today announces an update on the ongoing evaluation of its future operations. Reference is made to the announcement on 18th August 2025...
Read More